Загрузка...
Targeting the Vulnerability of RB Tumor Suppressor Loss in Triple-Negative Breast Cancer
Approximately 30% of triple-negative breast cancers (TNBCs) exhibit functional loss of the RB tumor suppressor, suggesting a target for precision intervention. Here, we use drug screens to identify agents specifically antagonized by the retinoblastoma tumor suppressor (RB) using CDK4/6 inhibitors. A...
Сохранить в:
| Опубликовано в: : | Cell Rep |
|---|---|
| Главные авторы: | , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
2018
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5967622/ https://ncbi.nlm.nih.gov/pubmed/29386107 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.celrep.2018.01.022 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|